Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration
Monica Dentice, Alessandro Marsili, Raffaele Ambrosio, Ombretta Guardiola, Annarita Sibilio, Ji-Hye Paik, Gabriella Minchiotti, Ronald A. DePinho, Gianfranco Fenzi, P. Reed Larsen, Domenico Salvatore
Monica Dentice, Alessandro Marsili, Raffaele Ambrosio, Ombretta Guardiola, Annarita Sibilio, Ji-Hye Paik, Gabriella Minchiotti, Ronald A. DePinho, Gianfranco Fenzi, P. Reed Larsen, Domenico Salvatore
View: Text | PDF
Research Article Muscle biology

The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration

  • Text
  • PDF
Abstract

The active thyroid hormone 3,5,3′ triiodothyronine (T3) is a major regulator of skeletal muscle function. The deiodinase family of enzymes controls the tissue-specific activation and inactivation of the prohormone thyroxine (T4). Here we show that type 2 deiodinase (D2) is essential for normal mouse myogenesis and muscle regeneration. Indeed, D2-mediated increases in T3 were essential for the enhanced transcription of myogenic differentiation 1 (MyoD) and for execution of the myogenic program. Conversely, the expression of T3-dependent genes was reduced and after injury regeneration markedly delayed in muscles of mice null for the gene encoding D2 (Dio2), despite normal circulating T3 concentrations. Forkhead box O3 (FoxO3) was identified as a key molecule inducing D2 expression and thereby increasing intracellular T3 production. Accordingly, FoxO3-depleted primary myoblasts also had a differentiation deficit that could be rescued by high levels of T3. In conclusion, the FoxO3/D2 pathway selectively enhances intracellular active thyroid hormone concentrations in muscle, providing a striking example of how a circulating hormone can be tissue-specifically activated to influence development locally.

Authors

Monica Dentice, Alessandro Marsili, Raffaele Ambrosio, Ombretta Guardiola, Annarita Sibilio, Ji-Hye Paik, Gabriella Minchiotti, Ronald A. DePinho, Gianfranco Fenzi, P. Reed Larsen, Domenico Salvatore

×

Figure 5

D2 expression in myoblasts is under direct FoxO3 control.

Options: View larger image (or click on image) Download as PowerPoint
D2 expression in myoblasts is under direct FoxO3 control.
(A) C2C12 or w...
(A) C2C12 or wild-type pp6 cells were transiently transfected with a FoxO3 or empty vector as indicated, and Dio2 mRNA measured 48 hours later by RT-PCR. (B) Left: Nuclear extracts from transfected cells with (+) or without (–) FoxO3 plasmid were analyzed by EMSA as indicated. Right: Schematic representation of mouse Dio2 proximal promoter region. Relevant binding sites and their mutant version are shown schematically. FoxO3 C.A, FoxO3 constitutively active; Comp., oligonucleotides used for competition (S, self oligo; U, unrelated oligo). (C) ChIP analysis of the interaction between FoxO3 and the mouse Dio2 promoter. Chromatin extracted from C2C12 cells was immunoprecipitated using the indicated antibodies. Unrel., unrelated genomic region. (D) Left: Dio2 mRNA in pp6 cells from wild-type and Foxo3+/– mice were cultured in proliferative and differentiating conditions and transfected with empty vector or a FoxO3 dominant-negative (FoxO D.N.) expression plasmid. Right: Dio2 mRNA in TA muscles from wild-type and Foxo3+/– mice. (E) Dio2 mRNA levels were measured by RT-PCR in shCTR or shFoxO3 cells. shFoxO3 cells were transfected with an RNAi-resistant FoxO3 plasmid as indicated. (F) pp6 cells from wild-type and Foxo3+/– mice were cultured in proliferative and differentiating conditions and treated with vehicle or 30 nM T3. MyoD mRNA was measured by RT-PCR. (G) MyoD mRNA levels in pp6 wild-type cells transfected with empty vector or FoxO C.A. or FoxO D.N. vector and treated with vehicle, T3, or rT3 as indicated. (H) Myogenin mRNA levels in pp6 from Dio2–/– mice cultured in proliferative and differentiating conditions and transfected with empty vector, FoxO3 C.A., or MyoD expression vectors. Values are mean ± SEM of at least 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts